Caredx, INC Form 4 insider transactions

CareDx, Inc. President and CEO John Walter Hanna Jr. reported a transaction involving the withholding of shares to cover tax obligations.

CareDx, Inc. CFO & COO Keith Kennedy acquired 11,725 shares of common stock for $17.87 per share, a transaction related to tax withholding obligations upon vesting of restricted stock units.

CareDx Chief Commercial Officer Jessica Meng reported a transaction involving the withholding of shares to cover tax obligations.

CareDx, Inc. officer Jeffrey Adam Novack reported a disposition of 3,987 shares of common stock on April 1, 2026, to cover tax withholding obligations.

Michael Goldberg, a Director at CareDx, Inc., received a quarterly stock grant of 1,981 shares as compensation.

CareDx Director Michael Goldberg reported exercising stock options for 26,500 shares of common stock, effective March 31, 2026, under a pre-arranged trading plan.

CareDx Chief Operating Officer Keith Kennedy increased his direct beneficial ownership of common stock through RSU awards and PRSU vesting, partially offset by shares withheld for tax obligations.

CareDx Chief Commercial Officer Jessica Meng reported the acquisition of restricted stock units and performance-based shares, alongside a disposition for tax withholding.

CareDx, Inc. Chief Financial Officer Nathan Smith reported significant acquisitions of restricted stock units and performance-based restricted stock units, alongside a tax-related share disposition.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, reported the acquisition of restricted stock units and performance-based units, alongside tax-related dispositions and a sale under a 10b5-1 trading plan.

CareDx, Inc. CEO John Walter Hanna JR reported the acquisition of 200,132 shares through RSU and PRSU awards, alongside a disposition of 13,694 shares for tax withholding.

CareDx Inc. President and CEO John Walter Hanna Jr. sold common stock totaling 19,480 shares in January 2026 under a pre-arranged Rule 10b5-1 trading plan.

CareDx Inc. President and CEO, John Walter Hanna Jr., sold 10,156 shares of common stock on January 15, 2026, under a pre-arranged 10b5-1 trading plan.

CareDx, Inc. Director Michael Goldberg received an automatic quarterly grant of 1,492 shares of common stock as non-employee director compensation.

CareDx Secretary and General Counsel Jeffrey Adam Novack sold 7,293 shares of common stock on December 4, 2025, under a pre-arranged 10b5-1 trading plan.

Jeffrey Adam Novack, CareDx's Secretary and General Counsel, reported the sale of 2,688 shares of common stock at $15.5219 per share, executed under a Rule 10b5-1 trading plan.

CareDx Secretary and General Counsel Jeffrey Adam Novack disposed of 2,152 shares of common stock to cover tax obligations related to restricted stock unit vesting.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, reported a future disposition of 2,872 common shares to cover tax liabilities from restricted stock unit vesting.

CareDx, Inc. Director Suresh Gunasekaran was granted 27,453 restricted stock units, vesting over three years.

CareDx, Inc. Director Michael Goldberg received an automatic grant of 1,753 shares of common stock as part of his non-employee director compensation.

CareDx, Inc.'s Chief Commercial Officer, Jessica Meng, disposed of 4,703 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

CareDx Chief Operating Officer Keith Kennedy reported the disposition of 7,987 common shares for tax withholding purposes at a price of $13.53 per share.

CareDx Director George Bickerstaff will acquire 29,136 common shares by exercising stock options at $7.96 per share on September 11, 2025, increasing his direct ownership.

CareDx, Inc. Chief Financial Officer Nathan Smith was granted 42,000 restricted stock units (RSUs) on August 7, 2025.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, plans to sell 2,688 shares of common stock under a pre-arranged 10b5-1 trading plan.

CareDx, Inc.'s Secretary and General Counsel, Jeffrey Adam Novack, had 2,873 shares withheld to cover tax obligations related to restricted stock unit vesting.

CareDx Chief Financial Officer Abhishek Jain disposed of 7,687 common shares to cover tax obligations from restricted stock unit vesting.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported a routine disposition of 276 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

CareDx, Inc. Director Peter Maag sold 10,000 shares of common stock at a weighted average price of $18.5831 per share on July 7, 2025, pursuant to a Rule 10b5-1 trading plan.

CareDx, Inc. Director Michael Goldberg received an automatic quarterly grant of 1,218 shares of common stock as non-employee director compensation, increasing his total beneficial ownership to 154,216 shares.